Literature DB >> 9870150

Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation.

Y H Ko1, S H Kim, H J Ree.   

Abstract

AIMS: Rosette-forming malignant lymphoma is very rare. We report a blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase (TdT) with formation of Homer-Wright type pseudorosettes. METHODS AND
RESULTS: An 18-year-old boy presented with an enlarged inguinal lymph node. Histologically, the nodal architecture of the lymph node was diffusely effaced by small to medium sized monomorphic blastoid lymphoid cells which frequently formed Homer-Wright type pseudorosettes. Immunophenotyping of the tumour using immunohistochemistry and flow cytometry revealed LCA+, CD4+, CD56+, CD43+, TdT+, CD2-, cCD3-, CD8-, CD7-, CD34- and TIA-1-. DNA analysis revealed no gene rearrangement of TCR beta and gamma genes. In situ hybridization for EBER 1 & 2 was negative. No azurophilic granules were found in the Wright stain. Complete remission was achieved with six cycles of chemotherapy with the CHOP regimen. The disease recurred in the paranasal sinuses and bone marrow 2 years later.
CONCLUSIONS: Immunophenotypic and genotypic similarities of the present case to those of TdT-negative blastic NK-cell lymphoma suggest that these diseases might be categorized as one entity irrespective of expression of TdT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870150     DOI: 10.1046/j.1365-2559.1998.00571.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Mantle cell lymphoma with Homer-Wright rosettes.

Authors:  Ida Münster Ikonomou; Jahn M Nesland; Svein Arve Schjølseth; Sverre Heim; Jan Delabie
Journal:  Virchows Arch       Date:  2002-12-19       Impact factor: 4.064

2.  CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma.

Authors:  Yoonjung Kim; Mi Seon Kang; Chan Whan Kim; Rohyun Sung; Young H Ko
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

3.  Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm

Authors:  Praveen Sharma; Shano Naseem
Journal:  Turk J Haematol       Date:  2020-04-15       Impact factor: 1.831

Review 4.  What is CD4+CD56+ malignancy and how should it be treated?

Authors:  P Reimer; T Rüdiger; D Kraemer; V Kunzmann; F Weissinger; A Zettl; H Konrad Müller-Hermelink; M Wilhelm
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.